Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ERCP: Complications and prophylaxis a controlled study.

J W Brandes, B Scheffer, H Lorenz-Meyer

    Endoscopy
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior.

    European archives of psychiatry and clinical neuroscience·2010
    Same author

    Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

    Gut·2001
    Same author

    Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins.

    The EMBO journal·1999
    Same author

    Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products.

    Human molecular genetics·1998
    Same author

    Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis.

    Alimentary pharmacology & therapeutics·1998
    Same author

    [Fish oil for prevention of Crohn disease recurrence].

    Zeitschrift fur Gastroenterologie·1998
    Same journal

    Correction: A novel technique for endoscopic stepwise clamping and resection of giant pedunculated colonic polyps.

    Endoscopy·2026
    Same journal

    Feasibility and safety of an adaptive endoscopic resection algorithm guided by the muscle-retracting sign for early rectal cancer.

    Endoscopy·2026
    Same journal

    Is ERCP losing its dominance to endoscopic ultrasound-guided biliary drainage for malignant distal biliary obstruction?

    Endoscopy·2026
    Same journal

    Endoscopic ultrasound-guided gallbladder drainage for distal malignant biliary obstruction: It's not the tool - but knowing which one to use!

    Endoscopy·2026
    Same journal

    Endoscopic closure of a large gastric mucosal defect using a novel endoscopic suturing device in a porcine model.

    Endoscopy·2026
    Same journal

    Anchor clip-assisted detachable loop ligation for definitive hemostasis and closure of a high-risk bleeding gastric ulcer.

    Endoscopy·2026
    See all related articles

    Prophylactic measures after Endoscopic Retrograde Cholangiopancreatography (ERCP) showed no significant benefit in preventing complications. Antibiotic or infusion prophylaxis did not reduce pancreatitis or bacterial issues in this controlled study.

    Area of Science:

    • Gastroenterology
    • Clinical Medicine
    • Medical Research

    Background:

    • Endoscopic Retrograde Cholangiopancreatography (ERCP) is a procedure associated with potential complications.
    • Preventing post-ERCP complications like pancreatitis and sepsis is crucial for patient outcomes.

    Purpose of the Study:

    • To investigate the efficacy of prophylactic measures in preventing complications following ERCP.
    • To compare the effectiveness of antibiotic prophylaxis and supportive care versus no intervention.

    Main Methods:

    • A controlled study involving 118 patients undergoing ERCP.
    • Patients were randomized into three groups: no treatment, oral tetracycline prophylaxis, or bed rest with infusion prophylaxis.
    • Complication rates, including pancreatitis and bacterial infections, were monitored and statistically analyzed.

    Related Experiment Videos

    Main Results:

    • The overall complication rate was 5%, with 2.5% pancreatitis and 2.5% bacterial complications.
    • No statistically significant differences were observed between the treatment groups regarding complication frequency.
    • Prophylactic measures did not influence the incidence or severity of temporary post-ERCP symptoms.

    Conclusions:

    • Neither antibiotic prophylaxis nor supportive care (bed rest, fasting, infusion) effectively prevents post-ERCP pancreatitis or bacterial complications.
    • Current prophylactic strategies do not appear to offer significant advantages in reducing ERCP-related adverse events.
    • Consideration of outpatient ERCP in select cases may be warranted given the low complication rates observed.